カテゴリー： GlobalInfoResearch, 世界

核酸ベース遺伝子治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Nucleic-Acid Based Gene Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102917）・商品コード：GIR9102917
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月23日（※2024年版があります。お問い合わせください）
・ページ数：123
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、核酸ベース遺伝子治療薬の世界市場について調べ、まとめました。種類別セグメントは、DNA、RNA等、用途別セグメントは、学術および政府研究所、製薬およびバイオテクノロジー企業、受託研究機関、病院および診断センター、その他等に区分しました。核酸ベース遺伝子治療薬の世界市場概観、企業動向、企業別核酸ベース遺伝子治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・核酸ベース遺伝子治療薬の市場概観
・核酸ベース遺伝子治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・核酸ベース遺伝子治療薬の企業別販売動向、市場シェア、市場集中度、競争動向
・核酸ベース遺伝子治療薬の世界市場規模
・核酸ベース遺伝子治療薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・核酸ベース遺伝子治療薬のアメリカ市場規模推移
・核酸ベース遺伝子治療薬のカナダ市場規模推移
・核酸ベース遺伝子治療薬のメキシコ市場規模推移
・核酸ベース遺伝子治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・核酸ベース遺伝子治療薬のドイツ市場規模推移
・核酸ベース遺伝子治療薬のイギリス市場規模推移
・核酸ベース遺伝子治療薬のロシア市場規模推移
・核酸ベース遺伝子治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・核酸ベース遺伝子治療薬の日本市場規模推移
・核酸ベース遺伝子治療薬の中国市場規模推移
・核酸ベース遺伝子治療薬の韓国市場規模推移
・核酸ベース遺伝子治療薬のインド市場規模推移
・核酸ベース遺伝子治療薬の東南アジア市場規模推移
・核酸ベース遺伝子治療薬の南米市場分析（ブラジル、アルゼンチン等）
・核酸ベース遺伝子治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・核酸ベース遺伝子治療薬の種類別分析/販売量、売上、市場シェア（DNA、RNA）
・核酸ベース遺伝子治療薬の用途別分析/市場規模（学術および政府研究所、製薬およびバイオテクノロジー企業、受託研究機関、病院および診断センター、その他）
・核酸ベース遺伝子治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・核酸ベース遺伝子治療薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Nucleic acid-based molecules are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.

Scope of the Report:
The global Nucleic-Acid Based Gene Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nucleic-Acid Based Gene Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Nucleic-Acid Based Gene Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nucleic-Acid Based Gene Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Wave Life Sciences
Phylogica
Benitec Biopharma
Celsion
Copernicus Therapeutics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
DNA
RNA

Market Segment by Applications, can be divided into
Academic and Government Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Hospitals and Diagnostic Centers
Others

【レポートの目次】

Table of Contents

1 Nucleic-Acid Based Gene Therapeutics Market Overview
1.1 Product Overview and Scope of Nucleic-Acid Based Gene Therapeutics
1.2 Classification of Nucleic-Acid Based Gene Therapeutics by Types
1.2.1 Global Nucleic-Acid Based Gene Therapeutics Revenue Comparison by Types (2019-2024)
1.2.2 Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Types in 2018
1.2.3 DNA
1.2.4 RNA
1.3 Global Nucleic-Acid Based Gene Therapeutics Market by Application
1.3.1 Global Nucleic-Acid Based Gene Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Academic and Government Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Contract Research Organizations
1.3.5 Hospitals and Diagnostic Centers
1.3.6 Others
1.4 Global Nucleic-Acid Based Gene Therapeutics Market by Regions
1.4.1 Global Nucleic-Acid Based Gene Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2014-2024)
1.5 Global Market Size of Nucleic-Acid Based Gene Therapeutics (2014-2024)
2 Manufacturers Profiles
2.1 Wave Life Sciences
2.1.1 Business Overview
2.1.2 Nucleic-Acid Based Gene Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Phylogica
2.2.1 Business Overview
2.2.2 Nucleic-Acid Based Gene Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Phylogica Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Benitec Biopharma
2.3.1 Business Overview
2.3.2 Nucleic-Acid Based Gene Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.4 Celsion
2.4.1 Business Overview
2.4.2 Nucleic-Acid Based Gene Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Celsion Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Copernicus Therapeutics
2.5.1 Business Overview
2.5.2 Nucleic-Acid Based Gene Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Nucleic-Acid Based Gene Therapeutics Market Competition, by Players
3.1 Global Nucleic-Acid Based Gene Therapeutics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Nucleic-Acid Based Gene Therapeutics Players Market Share
3.2.2 Top 10 Nucleic-Acid Based Gene Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Nucleic-Acid Based Gene Therapeutics Market Size by Regions
4.1 Global Nucleic-Acid Based Gene Therapeutics Revenue and Market Share by Regions
4.2 North America Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
4.3 Europe Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
4.5 South America Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Nucleic-Acid Based Gene Therapeutics Revenue by Countries
5.1 North America Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2014-2019)
5.2 USA Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
5.3 Canada Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
5.4 Mexico Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Nucleic-Acid Based Gene Therapeutics Revenue by Countries
6.1 Europe Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2014-2019)
6.2 Germany Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
6.3 UK Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
6.4 France Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
6.5 Russia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
6.6 Italy Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Countries
7.1 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2014-2019)
7.2 China Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
7.3 Japan Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
7.4 Korea Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
7.5 India Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Nucleic-Acid Based Gene Therapeutics Revenue by Countries
8.1 South America Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2014-2019)
8.2 Brazil Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
8.3 Argentina Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
8.4 Colombia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Nucleic-Acid Based Gene Therapeutics by Countries
9.1 Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
9.3 UAE Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
9.4 Egypt Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
9.6 South Africa Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Nucleic-Acid Based Gene Therapeutics Market Segment by Type
10.1 Global Nucleic-Acid Based Gene Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Global Nucleic-Acid Based Gene Therapeutics Market Forecast by Type (2019-2024)
10.3 DNA Revenue Growth Rate (2014-2024)
10.4 RNA Revenue Growth Rate (2014-2024)
11 Global Nucleic-Acid Based Gene Therapeutics Market Segment by Application
11.1 Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Application (2014-2019)
11.2 Nucleic-Acid Based Gene Therapeutics Market Forecast by Application (2019-2024)
11.3 Academic and Government Research Institutes Revenue Growth (2014-2019)
11.4 Pharmaceutical and Biotechnology Companies Revenue Growth (2014-2019)
11.5 Contract Research Organizations Revenue Growth (2014-2019)
11.6 Hospitals and Diagnostic Centers Revenue Growth (2014-2019)
11.7 Others Revenue Growth (2014-2019)
12 Global Nucleic-Acid Based Gene Therapeutics Market Size Forecast (2019-2024)
12.1 Global Nucleic-Acid Based Gene Therapeutics Market Size Forecast (2019-2024)
12.2 Global Nucleic-Acid Based Gene Therapeutics Market Forecast by Regions (2019-2024)
12.3 North America Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
12.4 Europe Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
12.6 South America Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Nucleic-Acid Based Gene Therapeutics Picture
Table Product Specifications of Nucleic-Acid Based Gene Therapeutics
Table Global Nucleic-Acid Based Gene Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Types in 2018
Figure DNA Picture
Figure RNA Picture
Table Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Application (2014-2024)
Figure Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Applications in 2018
Figure Academic and Government Research Institutes Picture
Figure Pharmaceutical and Biotechnology Companies Picture
Figure Contract Research Organizations Picture
Figure Hospitals and Diagnostic Centers Picture
Figure Others Picture
Table Global Market Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Table Wave Life Sciences Basic Information, Manufacturing Base and Competitors
Table Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Type and Applications
Table Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Phylogica Basic Information, Manufacturing Base and Competitors
Table Phylogica Nucleic-Acid Based Gene Therapeutics Type and Applications
Table Phylogica Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Benitec Biopharma Basic Information, Manufacturing Base and Competitors
Table Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Type and Applications
Table Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Celsion Basic Information, Manufacturing Base and Competitors
Table Celsion Nucleic-Acid Based Gene Therapeutics Type and Applications
Table Celsion Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Copernicus Therapeutics Basic Information, Manufacturing Base and Competitors
Table Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Type and Applications
Table Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Players (2014-2019)
Table Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Players (2014-2019)
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Players in 2017
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Players in 2018
Figure Global Top 5 Players Nucleic-Acid Based Gene Therapeutics Revenue Market Share in 2018
Figure Global Top 10 Players Nucleic-Acid Based Gene Therapeutics Revenue Market Share in 2018
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Regions (2014-2019)
Table Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Regions in 2018
Figure North America Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Europe Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure South America Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2014-2019)
Table North America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries in 2018
Figure USA Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Canada Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Mexico Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Europe Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure UK Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure France Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Russia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Italy Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries in 2018
Figure China Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Japan Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Korea Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure India Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2014-2019)
Table South America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Argentina Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Colombia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure UAE Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Egypt Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure Nigeria Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Figure South Africa Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Type (2014-2019)
Table Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Type (2014-2019)
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Type (2014-2019)
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Type in 2019
Table Global Nucleic-Acid Based Gene Therapeutics Revenue Forecast by Type (2019-2024)
Figure Global Nucleic-Acid Based Gene Therapeutics Market Share Forecast by Type (2019-2024)
Figure Global DNA Revenue Growth Rate (2014-2019)
Figure Global RNA Revenue Growth Rate (2014-2019)
Table Global Nucleic-Acid Based Gene Therapeutics Revenue by Application (2014-2019)
Table Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Application (2014-2019)
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Application (2014-2019)
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Application in 2019
Table Global Nucleic-Acid Based Gene Therapeutics Revenue Forecast by Application (2019-2024)
Figure Global Nucleic-Acid Based Gene Therapeutics Market Share Forecast by Application (2019-2024)
Figure Global Academic and Government Research Institutes Revenue Growth Rate (2014-2019)
Figure Global Pharmaceutical and Biotechnology Companies Revenue Growth Rate (2014-2019)
Figure Global Contract Research Organizations Revenue Growth Rate (2014-2019)
Figure Global Hospitals and Diagnostic Centers Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
Figure Europe Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
Figure South America Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2019-2024)


【掲載企業】

Wave Life Sciences、Phylogica、Benitec Biopharma、Celsion、Copernicus Therapeutics、

★調査レポート[核酸ベース遺伝子治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102917)販売に関する免責事項を必ずご確認ください。
★調査レポート[核酸ベース遺伝子治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 遺伝子編集技術の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103454 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、遺伝子編集技術の世界市場について調べ、まとめました。種類別セグメントは、二本鎖切断修復、設計されたヌクレアーゼ等、用途別セグメントは、遺伝子治療、病気の根絶等に区分しました。遺伝子編集技術の世界市場概観、企業動向、企業別遺伝子編集技術シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・遺伝子編集技術の市場概観 ・遺伝子編集技術の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・遺伝子編集技術の企業別販売動向、市場シェア、市場集中度、競争動向 ・遺伝子編集技術の世界市場規模 ・遺伝子編集技術の北米市場分析（アメリカ、カナダ、メキシコ等） ・遺伝子編集技術のアメリカ市場規模推移 ・遺伝子編集技術のカナダ市場規模推移 ・遺伝子編集技術のメキシコ市場規模推移 ・遺伝子編集技術のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Genome editing is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. Scope of the Report: The global Gene Editing Technologies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which...
  • 腫瘍学における遺伝子治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100702 / GlobalInfoResearch / 2019年9月5日 / 本調査レポートは、腫瘍学における遺伝子治療の世界市場について調べ、まとめました。種類別セグメントは、生体外、生体内等、用途別セグメントは、病院、診断センター、研究所等に区分しました。腫瘍学における遺伝子治療の世界市場概観、企業動向、企業別腫瘍学における遺伝子治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・腫瘍学における遺伝子治療の市場概観 ・腫瘍学における遺伝子治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・腫瘍学における遺伝子治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・腫瘍学における遺伝子治療の世界市場規模 ・腫瘍学における遺伝子治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・腫瘍学における遺伝子治療のアメリカ市場規模推移 ・腫瘍学における遺伝子治療のカナダ市場規模推移 ・腫瘍学における遺伝子治療のメキシコ市場規模推移 ・腫瘍学における遺伝子治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient.  Scope of the Report: The global Gene Therapy in Oncology market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot...
  • 遺伝子発現プロファイリングの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103453 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、遺伝子発現プロファイリングの世界市場について調べ、まとめました。種類別セグメントは、RNAシーケンス、リアルタイム定量PCR、デジタルPCR等、用途別セグメントは、研究機関、バイオサイエンス企業、その他等に区分しました。遺伝子発現プロファイリングの世界市場概観、企業動向、企業別遺伝子発現プロファイリングシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・遺伝子発現プロファイリングの市場概観 ・遺伝子発現プロファイリングの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・遺伝子発現プロファイリングの企業別販売動向、市場シェア、市場集中度、競争動向 ・遺伝子発現プロファイリングの世界市場規模 ・遺伝子発現プロファイリングの北米市場分析（アメリカ、カナダ、メキシコ等） ・遺伝子発現プロファイリングのアメリカ市場規模推移 ・遺伝子発現プロファイリングのカナダ市場規模推移 ・遺伝子発現プロファイリングのメキシコ市場規模推移 ・遺伝子発現プロファイリングのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Gene expression analysis is most simply described as the study of the way genes are transcribed to synthesize functional gene products. Scope of the Report: The global Gene Expression Profiling market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored....
  • 遺伝子合成サービスの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103785 / GlobalInfoResearch / 2019年9月30日 / 本調査レポートは、遺伝子合成サービスの世界市場について調べ、まとめました。種類別セグメントは、1000 bp未満、1001から3000 bp、3001から5000 bp、5000 bpを超える等、用途別セグメントは、コマーシャル、アカデミックリサーチ等に区分しました。遺伝子合成サービスの世界市場概観、企業動向、企業別遺伝子合成サービスシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・遺伝子合成サービスの市場概観 ・遺伝子合成サービスの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・遺伝子合成サービスの企業別販売動向、市場シェア、市場集中度、競争動向 ・遺伝子合成サービスの世界市場規模 ・遺伝子合成サービスの北米市場分析（アメリカ、カナダ、メキシコ等）...Description Scope of the Report: The global Gene Synthesis Service market is valued at 258.4 million USD in 2018 and is expected to reach 492.1 million USD by the end of 2024, growing at a CAGR of 17.5% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gene Synthesis Service. Europe also play important roles in...

    • ◆H&Iグローバルリサーチのお客様（例）◆